Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombolytic Therapy | 5 | 2026 | 41 | 2.520 |
Why?
|
| Stroke | 6 | 2026 | 261 | 2.400 |
Why?
|
| Fibrinolytic Agents | 5 | 2026 | 72 | 1.780 |
Why?
|
| Phantom Limb | 3 | 2020 | 9 | 0.920 |
Why?
|
| Heart-Assist Devices | 1 | 2026 | 33 | 0.920 |
Why?
|
| Terminology as Topic | 1 | 2026 | 64 | 0.920 |
Why?
|
| Ventricular Function, Left | 1 | 2026 | 115 | 0.900 |
Why?
|
| Retrospective Studies | 13 | 2026 | 2651 | 0.840 |
Why?
|
| Severity of Illness Index | 1 | 2026 | 468 | 0.830 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 123 | 0.790 |
Why?
|
| Heart Failure | 1 | 2026 | 253 | 0.780 |
Why?
|
| Cerebral Hemorrhage | 4 | 2025 | 93 | 0.750 |
Why?
|
| Atrial Fibrillation | 1 | 2026 | 404 | 0.710 |
Why?
|
| Middle Aged | 16 | 2026 | 7458 | 0.650 |
Why?
|
| Treatment Outcome | 7 | 2026 | 2430 | 0.590 |
Why?
|
| Aged | 11 | 2026 | 5627 | 0.560 |
Why?
|
| Aged, 80 and over | 7 | 2026 | 2070 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 843 | 0.490 |
Why?
|
| Male | 16 | 2026 | 14049 | 0.480 |
Why?
|
| Time-to-Treatment | 2 | 2025 | 33 | 0.450 |
Why?
|
| Female | 16 | 2026 | 15740 | 0.420 |
Why?
|
| Humans | 21 | 2026 | 29078 | 0.410 |
Why?
|
| Predictive Value of Tests | 2 | 2026 | 485 | 0.410 |
Why?
|
| Reproducibility of Results | 3 | 2026 | 788 | 0.390 |
Why?
|
| Time Factors | 6 | 2026 | 1619 | 0.370 |
Why?
|
| Autonomic Nervous System | 2 | 2026 | 118 | 0.340 |
Why?
|
| Motor Cortex | 2 | 2020 | 48 | 0.320 |
Why?
|
| Risk Factors | 5 | 2026 | 2138 | 0.300 |
Why?
|
| Chicago | 2 | 2026 | 9 | 0.280 |
Why?
|
| Intracranial Hemorrhages | 3 | 2024 | 32 | 0.260 |
Why?
|
| Cohort Studies | 2 | 2026 | 902 | 0.250 |
Why?
|
| Observer Variation | 1 | 2026 | 46 | 0.240 |
Why?
|
| Gastrostomy | 1 | 2025 | 8 | 0.240 |
Why?
|
| Health Resources | 1 | 2025 | 19 | 0.240 |
Why?
|
| Interoception | 1 | 2026 | 27 | 0.240 |
Why?
|
| Risk Assessment | 2 | 2026 | 631 | 0.240 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2025 | 6 | 0.240 |
Why?
|
| Prognosis | 2 | 2026 | 815 | 0.240 |
Why?
|
| Neurology | 1 | 2025 | 11 | 0.230 |
Why?
|
| Health Equity | 1 | 2025 | 17 | 0.230 |
Why?
|
| Hospital Mortality | 1 | 2026 | 159 | 0.230 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 56 | 0.220 |
Why?
|
| Vertebral Artery Dissection | 1 | 2024 | 4 | 0.220 |
Why?
|
| Palliative Care | 1 | 2025 | 87 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 105 | 0.210 |
Why?
|
| Disability Evaluation | 1 | 2024 | 54 | 0.210 |
Why?
|
| Rural Population | 1 | 2026 | 140 | 0.210 |
Why?
|
| Electrocardiography | 1 | 2026 | 398 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2024 | 123 | 0.210 |
Why?
|
| Registries | 1 | 2026 | 398 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 1 | 2025 | 225 | 0.200 |
Why?
|
| Adult | 6 | 2026 | 8080 | 0.200 |
Why?
|
| Amputees | 2 | 2020 | 7 | 0.190 |
Why?
|
| Neurovascular Coupling | 1 | 2024 | 154 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 383 | 0.180 |
Why?
|
| Telemedicine | 1 | 2025 | 214 | 0.180 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 32 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 271 | 0.170 |
Why?
|
| Cortical Excitability | 1 | 2020 | 2 | 0.160 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 17 | 0.160 |
Why?
|
| Gray Matter | 1 | 2020 | 24 | 0.160 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 37 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2020 | 46 | 0.160 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 26 | 0.160 |
Why?
|
| Functional Laterality | 1 | 2020 | 64 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2020 | 66 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 50 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 54 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2020 | 85 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 2020 | 88 | 0.150 |
Why?
|
| Aspirin | 1 | 2020 | 125 | 0.150 |
Why?
|
| Video Recording | 1 | 2019 | 41 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 191 | 0.150 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2017 | 16 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 69 | 0.120 |
Why?
|
| Administration, Intravenous | 2 | 2024 | 30 | 0.110 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2024 | 36 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 1009 | 0.110 |
Why?
|
| Length of Stay | 2 | 2025 | 246 | 0.090 |
Why?
|
| Recurrence | 2 | 2025 | 328 | 0.090 |
Why?
|
| United States | 2 | 2025 | 2252 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 426 | 0.070 |
Why?
|
| Perfusion Imaging | 1 | 2025 | 8 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2025 | 31 | 0.060 |
Why?
|
| Inpatients | 1 | 2025 | 60 | 0.060 |
Why?
|
| Illinois | 1 | 2024 | 3 | 0.050 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2024 | 2 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 99 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2025 | 271 | 0.050 |
Why?
|
| Rural Health Services | 1 | 2024 | 27 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2024 | 51 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 75 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 482 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 334 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 2855 | 0.040 |
Why?
|
| Hematoma | 1 | 2020 | 26 | 0.040 |
Why?
|
| Sensorimotor Cortex | 1 | 2020 | 7 | 0.040 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2020 | 14 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 22 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 51 | 0.040 |
Why?
|
| Amputation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 261 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 473 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 206 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2020 | 207 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 139 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 393 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 382 | 0.030 |
Why?
|
| Animals | 1 | 2026 | 10756 | 0.020 |
Why?
|